SCHEMBL6584846

SCHEMBL6584846

O=C(Cc1cccc(O)c1)c1cccc(O)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA6 P23280 1/20 0.53
CA9 Q16790 1/20 0.53
CTBP2 P56545 1/20 0.53
PARP1 P09874 1/20 0.52
KDM4E B2RXH2 2/20 0.52
ALDH1A1 P00352 1/20 0.52
EGLN2 Q96KS0 1/20 0.48
ENPP2 Q13822 1/20 0.48
CTNNB1 P35222 1/20 0.46
FASN P49327 1/20 0.46
DRD2 P14416 1/20 0.46
DRD1 P21728 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
HSD17B1 P14061 1/20 0.45
HSD17B2 P37059 1/20 0.45
CLK1 P49759 1/20 0.44
DYRK1A Q13627 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4833396 0.91 CTBP2 (0.56) CA12CA1CA2CA6CA9
SCHEMBL30396060 0.91 CA12 (0.57) CA12CA1CA2CA6CA9
SCHEMBL1515876 0.91 CA12 (0.57) CA12CA1CA2CA6CA9
SCHEMBL2937591 0.87 NPC1 (0.56) CTBP2KDM4EALDH1A1ENPP2HSD17B1
SCHEMBL24403579 0.82 HTT (0.50) CTBP2ENPP2HSD17B1HSD17B2NPC1
SCHEMBL4296495 0.82 CTBP2 (0.44) CA1CA2CA9CTBP2KDM4E
SCHEMBL30427127 0.79 CTBP2 (0.59) CA12CA1CA2CA6CA9
SCHEMBL22981807 0.79 CTBP2 (0.59) CA12CA1CA2CA6CA9
SCHEMBL27697248 0.78 MAPT (0.60) CTBP2KDM4EALDH1A1ENPP2CYP1A2
SCHEMBL11633589 0.78 MAPT (0.60) KDM4EALDH1A1CYP3A4ALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0784052-B1 Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation AVENTIS HOLDINGS INC (US) 2004-09-01 EP disclosed
EP-0784052-A1 Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1997-07-16 EP disclosed
US-4920131-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed
WO-1989012628-A1 QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-12-28 WO disclosed
EP-0348155-A1 Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1989-12-27 EP disclosed
US-4001216-A AMINOALKYL ETHERS OF 2,2'- AND 3,3'-DIHYDROXYDESOXYBENZOIN AMERICAN HOME PRODUCTS CORPORATION (US) 1977-01-04 US disclosed
US-4001216-A AMINOALKYL ETHERS OF 2,2'- AND 3,3'-DIHYDROXYDESOXYBENZOIN AMERICAN HOME PRODUCTS CORPORATION (US) 1977-01-04 US disclosed